Skip to main content
Erschienen in: BMC Surgery 1/2018

Open Access 01.12.2018 | Research article

Predictors of postoperative hypocalcemia occurring after a total thyroidectomy: results of prospective multicenter study

verfasst von: Vitalijus Eismontas, Algirdas Slepavicius, Vinsas Janusonis, Paulius Zeromskas, Virgilijus Beisa, Kestutis Strupas, Zilvinas Dambrauskas, Antanas Gulbinas, Arvydas Martinkenas

Erschienen in: BMC Surgery | Ausgabe 1/2018

Abstract

Background

Thyroid surgeries are among the most common operations performed in the world. Hypocalcemia following total thyroidectomy is a common complication that is sometimes difficult to correct. The aim of this study is to determine the risk factors for hypocalcemia following total thyroidectomy and their clinical value.

Methods

From January 2015 through to April 2017, 400 patients were included in this prospective multicenter study. All patients underwent total thyroidectomy due to various thyroid diseases. The following risk factors were analyzed: pre-operative and post-operative biochemical blood parameters, clinical effects and factors related to surgery, the patient, and the disease.

Results

Post-operative hypocalcemia developed in 257 patients (64.2%). Of them, 197 patients (76.7%) were diagnosed with asymptomatic hypocalcemia. Clinical symptoms were present in 60 of the 257 patients with hypocalcemia (23.3%). The statistically significant predictors of hypocalcemia were decreased calcium and ionized calcium pre-operatively (p < 0.001), parathyroid hormone on day one following surgery (p < 0.001), thyrotoxicosis <10 years before surgery (odds ratio 1.65, 95% CI 1.01–2.70, p = 0.046), the number of parathyroid glands found during surgery (odds ratio 0.52, 95% CI 0.38–0.70, p < 0.001), ligation of the trunk of the left inferior thyroid artery (odds ratio 2.04, 95% CI 1.27–3.29, p = 0.003), ligation of the trunk of the right inferior thyroid artery (odds ratio 2.37, 95% CI 1.47–3.81, p < 0.001), and the number of transplanted parathyroid glands (odds ratio 1.87, 95% CI 1.12–2.97, p = 0.015). In the multivariate analysis, age (odds ratio 1.05, 95% CI 1.01–1.09, p = 0.029) and gender (odds ratio 5.94, 95% CI 1.13–31.26, p = 0.035) were statistically significant predictors.

Conclusions

This study demonstrates that there is a number of different patient (gender, age, and duration of thyrotoxicosis <10 years before surgery) and surgical (number of parathyroid glands found during surgery, decreased calcium and ionized calcium before surgery, parathyroid hormone on day one following surgery, and ligation of the trunk of the left and right inferior thyroid artery) risk factors predictive of hypocalcemia following total thyroidectomy. Optimization of the surgical technique could possibly prevent the occurrence of hypocalcemia after total thyroidectomy in some cases; in other cases, identification of known risk factors post-operatively could permit early detection and effective treatment of these patients.
Abkürzungen
25-hydroxy Vit D
25-hydroxyvitamin D
Ca
Calcium
CIs
Confidence Intervals
iCa
ionized Calcium
LR
Likelihood Ratio
ORs
Odds Ratios
PGs
Parathyroid Glands
PTH
Parathyroid Hormone
TT
Total Thyroidectomy

Background

Thyroid surgeries are among the most common in the world [1]. Thyroid surgery is the definitive management option for thyroid malignancies, and also for benign diseases such as multinodular goiter with compression symptoms [2]. Hypocalcemia following total thyroidectomy (TT) is a relatively frequent complication, which is sometimes difficult to correct. Temporary hypocalcemia occurs in 50–68% of post-TT patients [3, 4], while permanent hypocalcemia occurs in 3% of post-TT patients [57]. Temporary hypocalcemia is defined by various authors as a post-surgery decrease in calcium (Ca), lasting for 6 to 12 months; permanent hypocalcemia is a post-TT decrease in Ca lasting for more than 12 months [8]. Post-TT hypocalcemia depends on a number of factors, including biochemical blood parameters before and after surgery, clinical effects and factors related to surgery, surgical technique, surgeon’s experience, the patient, and the disease [9].
The aim of this study was to determine the risk factors for postoperative hypocalcemia following TT and their clinical value.

Methods

From January 2015 to April 2017, 400 patients underwent surgeries for various thyroid diseases at Klaipėda University Hospital, Lithuania and Vilnius University Hospital Santaros Klinikos, Lithuania. Permission from the Lithuanian Bioethics Committee was obtained for this prospective multicenter research (2014-12-02, No.: L-14-09/1, No.: L-14-09/2). All patients signed a consent form before surgery. The inclusion criteria for this study were thyroid nodules in 361 patients (90.3%), thyroid carcinoma in 84 patients (21%), thyroiditis in 37 patients (9.3%). Some patients had more than one indication for surgery. The exclusion criteria for this study were previous hemithyroidectomy, lobectomy, resection of thyroid gland, and diagnosed pathology of parathyroid glands (PGs). In this study all operations were performed by a three high-volume thyroid surgeons. Various factors that may influence post-TT hypocalcemia were investigated, including pre-operative and post-operative biochemical blood parameters, clinical effects and factors related to surgery, the patient, and the disease. Postoperative hypocalcemia was diagnosed when the level of Ca in the blood was <2.10 mmol/L. Before surgery, Ca, ionized calcium (iCa), parathyroid hormone (PTH), 25-hydroxyvitamin D (25-hydroxy Vit D), and thyroid hormones were measured. Length of stay in hospital for patients following the surgery was 2 days. Measurements following TT on the first and second day at six oʼclock in the morning were performed. On day one following the surgery, Ca, iCa, and PTH were measured. On day two following the surgery, Ca, iCa were measured. Clinical expression of post-operative hypocalcemia, and the time when the disease manifested, were assessed. The impact of surgery-related factors on post-operative hypocalcemia was analyzed, including the number of PGs observed during the surgery, number of autotransplanted PGs, and ligation of vessels supplying blood to the thyroid gland. Oral Ca with/without calcitriol were not routinely given unless patients had symptoms or serum Ca < 2 mmol/L. Oral Ca 1500–3000 mg with/without calcitriol 0.25 mcg twice daily were appointed for 2 weeks following the surgery. Calcitriol should be given in case a higher risk of postoperative hypocalcemia, including recurrent neck surgery, central neck dissection, intraoperative PG injury, autotransplanted PGs, also for patients with low postoperative PTH and 25-hydroxy Vit D deficiency.
All blood samples were taken from a peripheral vein. 25-hydroxy Vit D and PTH were measured with Cobas e411 analyzer (Roche Diagnostics, Mannheim, Germany). The normal range of 25-hydroxy Vit D in the blood is 75.00–106.75 nmol/L for men and 75.00–124.75 nmol/L for women. The normal PTH range is 15.00–65.00 pg/mL. The level of Ca and iCa was determined with Architect ci8200 analyzer (Abbot, Wiesbaden, Germany).
The normal range of Ca in the blood is 2.10–2.55 mmol/L and the normal range of iCa in the blood is 1.00–1.30 mmol/L.

Statistical analysis

Data analysis was performed using SPSS version 24.0 and MS Excel 2016. Univariate descriptive statistics were performed for the continuous data. Categorical data were summarized as frequencies and percentages. The chi-square test or the Fishers exact test was used to estimate the associations between categorical variables. Comparison of proportions between the groups was performed using the z test. After testing for normality, parametric or non-parametric tests were performed, as required. Comparison of health variables between hypocalcemia (no (0), yes (1)) groups was performed using the Students t test and the Mann–Whitney test. ANOVA and the Kruskal–Wallis test was employed for comparison of two or more groups. Univariate binary logistic regression analysis was used to determine the relative significance of sociodemographic and perceived health variables as predictors of hypocalcemia. Variables associated with post-operative hypocalcemia in univariate analyses were incorporated into a multivariate logistic regression to identify independent risk factors for post-operative hypocalcemia following thyroidectomy. Multivariate logistic regression analysis, using the backward LR (Likelihood Ratio) test, was employed to remove variables with p > 0.1. Odds ratios (ORs) of statistically significant predictors are presented with 95% confidence intervals (CIs). A p value of less than 0.05 was taken to indicate statistical significance.

Results

From January 2015 to April 2017, 400 patients underwent TT’s. There were 349 women (87.2%) and 51 men (12.8%). The mean age was 57.2 years and the mean weight was 79.2 kg. According to the data, post-operative hypocalcemia developed in 257 patients (64.2%). Of them, 197 patients (76.7%) were diagnosed with asymptomatic hypocalcemia. Clinical symptoms were observed in 60 patients (23.3%) of the 257 patients with hypocalcemia. Numbness of fingers was observed in 58 patients (22.6% of the patients with post-operative hypocalcemia). Chvostek’s signs were present in 14 patients (5.4% of the patients with post-operative hypocalcemia). Trousseau’s signs were present in eight patients (3.1% of the patients with post-operative hypocalcemia). In the group of patients with post-operative hypocalcemia, one symptom was present in 44 patients (17.1%), two symptoms were present in 11 patients (4.3%), and three symptoms were observed in five patients (1.9%). See Tables 1 and 2 for details.
Table 1
Patient demographics and clinical characteristics
Variablea
Value
Gender, n (%)
400 (100)
 Female
349 (87.2)
 Male
51 (12.8)
Age in years, mean (SD)
57.2 (13.4)
Weight in kg, mean (SD)
79.2 (15.8)
Thyrotoxicosis before surgery, n (%)
 No
277 (69.2)
 <10 years
105 (26.3)
 ≥10 years
18 (4.5)
Graves’ disease, n (%)
 No
379 (94.7)
 Yes
21 (5.3)
Recurrent goiter, n (%)
 No
397 (99.2)
 Yes
3 (0.8)
Retrosternal goiter, n (%)
 No
393 (98.2)
 Yes
7 (1.8)
Bone mass density, T level, n (%)
 No
394 (98.5)
 Yes
6 (1.5)
Preoperative calcium, mmol/L, mean (SD)
2.36 (0.10)
MD (IQR)
2.36 (0.12)
Preoperative ionized calcium, mmol/L, mean (SD)
1.06 (0.08)
MD (IQR)
1.04 (0.07)
Preoperative PTH, ng/L (pg/mL), mean (SD)
57.71 (22.27)
MD (IQR)
53.90 (26.63)
Preoperative 25-hydroxyvitamin D, nmol/L, mean (SD)
45.27 (22.03)
MD (IQR)
41.78 (29.72)
Preoperative TSH, mlU/L, mean (SD)
0.94 (1.22)
MD (IQR)
0.75 (1.22)
Preoperative FT3, pmol/L, mean (SD)
4.87 (2.36)
MD (IQR)
4.66 (0.84)
Preoperative FT4, pmol/L, mean (SD)
13.31 (2.69)
MD (IQR)
13.43 (2.71)
Thyroidectomy without lymphadenectomy, n (%)
400 (100)
 No
66 (16.5)
 Yes
334 (83.5)
Thyroidectomy with one sided central lymphadenectomy, n (%)
 No
344 (86.0)
 Yes
56 (14.0)
Thyroidectomy with central lymphadenectomy on both sides, n (%)
 No
390 (97.5)
 Yes
10 (2.5)
Number of observed parathyroid glands, n (%)
 0
2 (0.5)
 1
8 (2.0)
 2
97 (24.2)
 3
208 (52.0)
 4
85 (21.3)
Upper branch of left inferior thyroid artery, n (%)
 Non-ligation
363 (90.7)
 Ligation
37 (9.3)
Lower branch of left inferior thyroid artery, n (%)
 Non-ligation
366 (91.5)
 Ligation
34 (8.5)
Trunk of left inferior thyroid artery, n (%)
 Non-ligation
90 (22.5)
 Ligation
310 (77.5)
Upper branch of right inferior thyroid artery, n (%)
 Non-ligation
358 (89.5)
 Ligation
42 (10.5)
Lower branch of right inferior thyroid artery, n (%)
 Non-ligation
366 (91.5)
 Ligation
34 (8.5)
Trunk of right inferior thyroid artery, n (%)
 Non-ligation
91 (22.8)
 Ligation
309 (77.2)
Number of darkened parathyroid glands at the end of surgery, n (%)
 0
305 (76.2)
 1
80 (20.0)
 2
9 (2.3)
 3
6 (1.5)
Parathyroid gland hematoma, n (%)
 No
379 (94.7)
 Yes
21 (5.3)
Number of autotransplanted parathyroid glands, n (%)
 0
332 (83.0)
 1
54 (13.4)
 2
11 (2.8)
 3
3 (0.8)
Adenomatous nodules, n (%)
 No
334 (83.5)
 Yes
66 (16.5)
Colloidal nodules, n (%)
 No
130 (32.5)
 Yes
270 (67.5)
Papillary carcinoma, n (%)
 No
320 (80.0)
 Yes
80 (20.0)
Follicular carcinoma, n (%)
 No
399 (99.7)
 Yes
1 (0.3)
Medullary carcinoma, n (%)
 No
397 (99.3)
 Yes
3 (0.8)
Anaplastic carcinoma, n (%)
 No
400 (100)
Autoimmune thyroiditis, n (%)
 No
363 (90.7)
 Yes
37 (9.3)
Calcium day one, mmol/L, mean (SD)
2.12 (0.14)
MD (IQR)
2.11 (0.20)
Ionized calcium day one, mmol/L, mean (SD)
0.99 (0.08)
MD (IQR)
0.99 (0.10)
PTH day one, ng/L (pg/mL), mean (SD)
29.98 (19.46)
MD (IQR)
29.06 (27.61)
Calcium day two, mmol/L, mean (SD)
2.05 (0.16)
MD (IQR)
2.06 (0.22)
Ionized calcium day two, mmol/L, mean (SD)
0.98 (0.09)
MD (IQR)
0.98 (0.11)
Revision for bleeding, n (%)
 No
396 (99.0)
 Yes
4 (1.0)
Wound infection, n (%)
 No
400 (100)
Wound hematoma, n (%)
 No
389 (97.2)
 Yes
11 (2.8)
Bleeding during surgery, n (%)
 No
399 (99.7)
 Yes
1 (0.3)
Clinical voice hoarseness, n (%)
 No
384 (96.0)
 Yes
16 (4.0)
Recurrent laryngeal nerve paralysis on one side, ORL, n (%)
 No
392 (98.0)
 Yes
8 (2.0)
Recurrent laryngeal nerve paralysis on both sides, ORL, n (%)
 No
400 (100)
Clinical manifestation of hypocalcemia, n (%)
 None
340 (85.0)
 Day one
14 (3.5)
 Day two
46 (11.5)
Hypocalcemia without clinical manifestation, n (%)
 No
203 (50.7)
 Yes
197 (49.3)
Hypocalcemia - Chvostekʼs symptoms, n (%)
 No
386 (96.5)
 Yes
14 (3.5)
Hypocalcemia - Trousseau’s symptoms, n (%)
 No
392 (98.0)
 Yes
8 (2.0)
Hypocalcemia - Numbness of fingers, n (%)
 No
342 (85.5)
 Yes
58 (14.5)
Hypocalcemia, n (%)
 No
143 (35.8)
 Yes
257 (64.2)
Treatment commenced in hospital with calcium and vitamin D preparations after surgery, n (%)
 None
161 (40.3)
 Day 1
15 (3.8)
 Day 2
33 (8.3)
 Day 3
5 (1.3)
 On discharge
186 (46.5)
aContinuous variables are presented as means and standard deviations (SD) & medians (MD) and interquartile ranges (IQR); categorical variables are presented as n (%). PTH Parathyroid hormone, TSH thyroid stimulating hormone; FT3 free triiodothyronine, FT4 free thyroxine, ORL otorhinolaryngologist
Table 2
Patient characteristics
Variablesa
Hypocalcemia
p value
Yes
No
Gender, n (%)
257
143
 
 Female
221 (63.3)
128 (36.7)
χ2 = 1.02, df = 1, p = 0.351
 Male
36 (70.6)
15 (29.4)
Age in years, mean (SD)
57.8 (13.2)
56.0 (13.8)
0.207
Weight, kg., mean (SD)
79.0 (15.2)
79.5 (16.8)
0.721
Thyrotoxicosis before surgery, n (%)
 No
170 (66.1)
107 (74.8)
χ2 = 4.10, df = 2, p = 0.129
 <10 years
76 (29.6)
29 (20.3)
 ≥10 years
11 (4.3)
7 (4.9)
Graves’ disease, n (%)
 No
241 (93.8)
138 (96.5)
χ2 = 1.38, df = 1, p = 0.350
 Yes
16 (6.2)
5 (3.5)
Recurrent goiter, n (%)
 No
254 (98.8)
143 (100)
χ2 = 1.68, df = 1, p = 0.556
 Yes
3 (1.2)
0
Retrosternal goiter, n (%)
 No
250 (97.3)
143 (100)
χ2 = 3.96, df = 1, p = 0.053
 Yes
7 (2.7)
0
Bone mass density, T level, n (%)
 No
394 (98.5)
394 (98.5)
χ2 = 0.54, df = 1, p = 0.671
 Yes
6 (1.5)
6 (1.5)
Preoperative calcium, mmol/L, mean (SD)b
2.35 (0.09)
2.39 (0.11)
< 0.001
MD (IQR)
2.35 (0.11)
2.39 (0.12)
Preoperative ionized calcium, mmol/L, mean (SD)b
1.04 (0.07)
1.08 (0.10)
< 0.001
MD (IQR)
1.03 (0.07)
1.07 (0.09)
Preoperative PTH, ng/L (pg/mL), mean (SD)b
57.86 (22.18)
57.43 (22.50)
0.855
MD (IQR)
54.17 (26.38)
53.65 (26.05)
Preoperative 25-hydroxyvitamin D, nmol/L, mean (SD)c
44.22 (22.97)
47.16 (20.17)
0.053
MD (IQR)
40.35 (30.47)
46.40 (26.69)
Preoperative TSH, mlU/L, mean (SD)c
1.12 (1.33)
0.96 (0.97)
0.355
MD (IQR)
0.80 (1.20)
0.70 (1.17)
Preoperative FT3, pmol/L, mean (SD)b
4.85 (2.73)
4.90 (1.50)
0.854
MD (IQR)
4.60 (0.83)
4.71 (0.93)
Preoperative FT4, pmol/L, mean (SD)b
13.53 (2.47)
13.67 (3.05)
0.626
MD (IQR)
13.45 (2.92)
13.40 (2.36)
Thyroidectomy without lymphadenectomy, n (%)
 No
48 (18.7)
18 (12.6)
χ2 = 2.47, df = 1, p = 0.124
 Yes
209 (81.3)
125 (87.4)
Thyroidectomy with one sided central lymphadenectomy, n (%)
 No
216 (84.0)
128 (89.5)
χ2 = 2.28, df = 1, p = 0.175
 Yes
41 (16.0)
15 (10.5)
Thyroidectomy with central lymphadenectomy on both sides, n (%)
 No
250 (97.3)
140 (97.9)
χ2 = 0.15, df = 1, p = 1.000
 Yes
7 (2.7)
3 (2.1)
Number of observed parathyroid glands, n (%)
 0
2 (0.8)
0
χ2 = 35.23, df = 4, p < 0.001
 1
3 (1.2)
5 (3.5)
 2
76 (29.6)**
21 (14.7)**
 3
142 (55.3)
66 (46.2)
 4
34 (13.2)***
51 (36.7)***
Upper branch of left inferior thyroid artery, n (%)
 Non-ligation
231 (89.9)
132 (92.3)
χ2 = 0.64, df = 1, p = 0.475
 Ligation
26 (10.1)
11 (7.7)
Lower branch of left inferior thyroid artery, n (%)
 Non-ligation
232 (90.3)
134 (93.7)
χ2 = 1.39, df = 1, p = 0.267
 Ligation
25 (9.7)
9 (6.3)
Trunk of left inferior thyroid artery, n (%)
 Non-ligation
46 (17.9)
44 (30.8)
χ2 = 8.73, df = 1, p = 0.003
 Ligation
211 (82.1)
99 (69.2)
Upper branch of right inferior thyroid artery, n (%)
 Non-ligation
232 (90.3)
126 (88.1)
χ2 = 0.46, df = 1, p = 0.501
 Ligation
25 (9.7)
17 (11.9)
Lower branch of right inferior thyroid artery, n (%)
 Non-ligation
231 (89.9)
135 (94.4)
χ2 = 2.42, df = 1, p = 0.137
 Ligation
26 (10.1)
8 (5.6)
Trunk of right inferior thyroid artery, n (%)
 Non-ligation
44 (17.1)
47 (32.9)
χ2 = 12.96, df = 1, p < 0.001
 Ligation
213 (82.9)
96 (67.1)
Number of darkened parathyroid glands at the end of surgery, n (%)
 0
194 (75.5)
111 (77.6)
χ2 = 3.64, df = 3, p = 0.303
 1
54 (21.0)
26 (18.2)
 2
7 (2.7)
2 (1.4)
 3
2 (0.8)
4 (2.8)
Parathyroid gland hematoma, n (%)
 No
244 (94.9)
135 (94.4)
χ2 = 0.05, df = 1, p = 0.818
 Yes
13 (5.1)
8 (5.6)
Number of autotransplanted parathyroid glands, n (%)
 0
205 (79.8)*
127 (88.8)*
χ2 = 6.32, df = 3, p = 0.097
 1
40 (15.6)
14 (9.8)
 2
9 (3.5)
2 (1.4)
 3
3 (1.2)
0
Adenomatous nodules, n (%)
 No
218 (84.8)
116 (81.1)
χ2 = 0.92, df = 1, p = 0.399
 Yes
39 (15.2)
27 (18.9)
Colloidal nodules, n (%)
 No
81 (31.5)
49 (34.3)
χ2 = 0.32, df = 1, p = 0.579
 Yes
176 (68.5)
94 (65.7)
Papillary carcinoma, n (%)
 No
203 (79.0)
142 (99.3)
χ2 = 0.46, df = 1, p = 0.518
 Yes
54 (21.0)
26 (18.2)
Follicular carcinoma, n (%)
 No
257 (100)
399 (99.3)
χ2 = 1.80, df = 1, p = 0.358
 Yes
0
1 (0.7)
Medullary carcinoma, n (%)
 No
254 (98.8)
143 (100)
χ2 = 1.68, df = 1, p = 0.556
 Yes
3 (1.2)
0
Anaplastic carcinoma, n (%)
 No
257 (100)
143 (100)
 
Autoimmune thyroiditis, n (%)
 No
234 (91.1)
129 (90.2)
χ2 = 0.08, df = 1, p = 0.857
 Yes
23 (8.9)
14 (9.8)
Calcium day one, mmol/L, mean (SD)
2.05 (0.12)
2.24 (0.11)
< 0.001
MD (IQR)
2.05 (0.16)
2.25 (0.13)
Ionized calcium day one, mmol/L, mean (SD)
0.96 (0.07)
1.06 (0.07)
< 0.001
MD (IQR)
0.96 (0.08)
1.05 (0.09)
PTH, ng/L (pg/mL), mean (SD)
24.42 (18.27)
39.97 (17.50)
< 0.001
MD (IQR)
21.47 (29.24)
38.09 (20.86)
Calcium day two, mmol/L, mean (SD)
1.96 (0.12)
2.20 (0.08)
< 0.001
MD (IQR)
1.99 (0.18)
2.19 (0.11)
Ionized calcium day two, mmol/L, mean (SD)
0.94 (0.07)
1.06 (0.07)
< 0.001
MD (IQR)
0.94 (0.09)
1.05 (0.08)
Revision for bleeding, n (%)
 No
254 (98.8)
142 (99.3)
χ2 = 0.20, df = 1, p = 1.000
 Yes
3 (1.2)
1 (0.7)
Wound infection, n (%)
 No
257 (100)
143 (100)
 
Wound hematoma, n (%)
 No
249 (96.9)
140 (97.9)
χ2 = 0.35, df = 1, p = 0.753
 Yes
8 (3.1)
3 (2.1)
Bleeding during surgery, n (%)
 No
256 (99.6)
143 (100)
χ2 = 0.56, df = 1, p = 1.000
 Yes
1 (0.4)
0
Clinical voice hoarseness, n (%)
 No
245 (95.3)
139 (97.2)
χ2 = 0.84, df = 1, p = 0.434
 Yes
12 (4.7)
4 (2.8)
Recurrent laryngeal nerve paralysis on one side, ORL, n (%)
 No
252 (98.1)
140 (97.9)
χ2 = 0.84, df = 1, p = 0.434
 Yes
5 (1.9)
3 (2.1)
Recurrent laryngeal nerve paralysis on both sides, ORL, n (%)
 No
257 (100)
143 (100)
 
Clinical manifestation of hypocalcemia, n (%)
 None
197 (76.7)
143 (100)
χ2 = 39.27, df = 2, p < 0.001
 Day 1
14 (3.5)
0
 Day 2
46 (17.9)
0
Hypocalcemia without clinical manifestation, n (%)
 No
60 (23.3)
143 (100)
χ2 = 215.99, df = 1, p < 0.001
 Yes
197 (76.7)
0
Hypocalcemia - Chvostekʼs symptoms, n (%)
 No
243 (94.6)
143 (100)
χ2 = 8.07, df = 1, p = 0.004
 Yes
14 (5.4)
0
Hypocalcemia - Trousseau’s symptoms, n (%)
 No
249 (96.9)
143 (100)
χ2 = 4.54, df = 1, p = 0.033
 Yes
8 (2.0)
0
Hypocalcemia - Numbness of fingers, n (%)
 No
199 (77.4)
143 (100)
χ2 = 37.75, df = 1, p < 0.001
 Yes
58 (22.6)
0
Treatment commenced in hospital with calcium and vitamin D preparations after surgery, n (%)
 None
23 (8.9)
139 (97.2)
χ2 = 297.04, df = 4, p < 0.001
 Day 1
15 (5.8)
0)
 Day 2
33 (12.8)
0
 Day 3
5 (1.9)
0
 On discharge
181 (70.3)
4 (2.8)
aContinuous variables are presented as means and standard deviations (SD) & medians and interquartile ranges (IQR); categorical variables are presented as n (%). bStudent t test; cMann-Whitney U test. * p < 0.05, z test, ** p < 0.01, *** p < 0.001. PTH Parathyroid hormone, ORL otorhinolaryngologist
Comparison of the patients with diagnosed hypocalcemia following surgery and the patients without diagnosis of hypocalcemia showed that the following variables were significantly related to the development of hypocalcemia: decreased pre-operative Ca (p < 0.001), and decreased pre-operative iCa (p < 0.001). Our study did not showed an increased risk of postoperative hypocalcemia in the case of malignancy: papillary carcinoma (p = 0.518), follicular carcinoma (p = 0.358), medullary carcinoma (p = 0.556), and bilateral central neck dissection (p = 1.000), wound hematoma (p = 0.753), bleeding during surgery (p = 1.000), revision for bleeding (p = 1.000). These data are presented in Table 2.
Univariate analysis revealed that thyrotoxicosis <10 years before surgery was a predisposing factor for hypocalcemia (OR 1.65, 95% CI 1.01–2.70, p = 0.046). The number of PGs observed during surgery was also statistically associated with post-operative hypocalcemia (OR 0.52, 95% CI 0.38–0.70, p < 0.001). Ligation of the trunk of the left inferior thyroid artery (OR 2.04, 95% CI 1.27–3.29, p = 0.003) and the trunk of the right inferior thyroid artery (OR 2.37, 95% CI 1.47–3.82, p < 0.001) were statistically significant factors related to post-operative hypocalcemia. The number of PGs autotransplanted during surgery was also significantly associated with post-TT hypocalcemia (OR 1.87, 95% CI 1.12–2.97, p = 0.015). Finally, PTH on day one following the surgery was a statistically significant predictor of post-operative hypocalcemia (OR 0.96, 95% CI 0.94–0.97, p < 0.001). This data is presented in Table 3.
Table 3
Associations between patient characteristics and risk of hypocalcemia - Univariate model
Variable
OR
95% CI
p
Thyrotoxicosis before surgery: no
1
 
0.132
<10 years
1.65
1.01–2.70
0.046
>10 years
0.99
0.37–2.63
0.982
Thyroidectomy without lymphadenectomy
0.63
0.35–1.13
0.118
Thyroidectomy with one sided central lymphadenectomy
1.62
0.86–3.04
0.134
Thyroidectomy with central lymphadenectomy on both sides
1.31
0.33–5.13
0.702
Upper branch of left inferior thyroid artery, ligation
0.74
0.35–1.55
0.424
Lower branch of left inferior thyroid artery, ligation
0.62
0.28–1.38
0.241
Trunk of left inferior thyroid artery, ligation
2.04
1.27–3.29
0.003
Upper branch of right inferior thyroid artery, ligation
1.25
0.65–2.41
0.500
Lower branch of right inferior thyroid artery, ligation
1.90
0.84–4.31
0.125
Trunk of right inferior thyroid artery, ligation
2.37
1.47–3.82
<0.001
Number of darkened parathyroid glands at the end of surgery
0.98
0.69–1.39
0.925
Parathyroid gland hematoma
0.90
0.36–2.22
0.818
Adenomatous nodules
0.77
0.45–1.32
0.339
Colloidal nodules
1.13
0.73–1.75
0.574
Papillary carcinoma
1.20
0.71–2.01
0.498
Autoimmune thyroiditis
0.91
0.45–1.82
0.781
Graves’ disease
0.55
0.20–1.52
0.247
Calcium before surgery
0.01
1.01–0.57
<0.001
Calcium, day 1 after surgery
0.00
0.00–0.00
<0.001
Calcium, day 2 after surgery
0.00
0.00–0.00
<0.001
Ionized calcium before surgery
0.001
0.000–0.013
<0.001
Ionized calcium, day 1 after surgery
0.00
0.00–0.00
<0.001
Ionized calcium, day 2 after surgery
0.00
0.00–0.00
<0.001
PTH before surgery
1.00
0.99–1.01
0.854
PTH, day 1 after surgery
0.96
0.94–0.97
<0.001
25-hydroxyvitamin D before surgery
0.99
0.99–1.00
0.201
TSH before surgery
1.13
0.94–1.36
0.197
FT4 before surgery
0.98
0.91–1.06
0.625
FT3 before surgery
0.99
0.91–1.08
0.854
PTH Parathyroid hormone, TSH thyroid stimulating hormone, FT3 free triiodothyronine, FT4 free thyroxine
Unlike the univariate analysis, multivariate analysis revealed that older age (OR 1.05, 95% CI 1.01–1.09, p = 0.029) and female gender (OR 5.94, 95% CI 1.13–31.26, p = 0.035) were statistically significant independent predictors of post-operative hypocalcemia. See Table 4.
Table 4
Associations between patient characteristics and risk of hypocalcemia - Multivariate model
Variable
OR
95% CI
p
Age
1.05
1.01–1.09
0.029
Gender
5.94
1.13–31.26
0.035
Calcium, second day after surgery
0.00
0.00–0.00
<0.001
OR Odds ratio, CI confidence interval

Discussion

Post-TT hypocalcemia is one of the most common complications [10]. According to the literature, post-TT hypocalcemia occurs in 50–68% of patients [3, 4]. In our study, post-TT hypocalcemia developed in 64.2% of the patients. In the literature, the majority of patients exhibit asymptomatic hypocalcemia and need no treatment, or only oral administration of Ca and vitamin D preparations [11]. In our study, 197 patients had asymptomatic hypocalcemia (49.3% of all the patients who participated in the study, or 76.7% of the patients with post-operative hypocalcemia). Less than half of the patients received no treatment after TT (161; 40.3%). The patients who received treatments were prescribed oral or intravenous preparations of Ca and vitamin D, depending on the time of expression and intensity of clinical symptoms (Table 2). Overall, 60 patients (15% of all the patients who participated in the study, or 23.3% of the patients with post-operative hypocalcemia) had one, two, or three clinical symptoms of hypocalcemia. In a multicenter study with 14,934 patients, Rosato et al. found that 10% of patients had symptomatic hypocalcemia [3]. However, that study included patients who had TT (64.3%) and smaller-scale surgeries on the thyroid (35.7%) [3]. In our study, decreased pre-operative Ca and iCa were statistically significant predictors of post-operative hypocalcemia (p < 0.001). Several studies have found that temporary post-operative hypocalcemia develops more often in patients who have a markedly decreased level of Ca before surgery [1218]. However, a meta-analysis of six studies with 2493 patients did not reveal a statistically reliable association between pre-operative Ca and the frequency of temporary hypocalcemia [1721]. A sharp decrease in Ca after TT is associated with temporary hypocalcemia [12, 2224]. In a multicenter study with 1157 patients, Hallgrimsson et al. found that patients who experienced a 2–3% decrease in post-operative Ca in the 24 h following surgery, in comparison with the pre-operative level of Ca, had a 94% chance of developing temporary hypocalcemia [25]. Changes in the levels of Ca in the blood during the first 24 h following surgery allow prediction of temporary hypocalcemia with 19–91% sensitivity [2630]. A blood Ca concentration of 1.88 mmol/L or less during the first 24 h after surgery has been associated with permanent hypocalcemia [31]. Two other studies have demonstrated that there is an increased risk of developing permanent hypocalcemia if the level of Ca in the blood remains at 2 mmol/L or less, 1–3 weeks after surgery [32, 33]. Tartaglia et al. revealed that measurement of iCa was more reliable than measurement of Ca in post-TT patients, in the immediate and long-term follow-up [34].
Based on our data, decreased PTH during the first 24 h after surgery was a statistically reliable predictor of post-operative hypocalcemia (p < 0.001). In many other studies, a decrease in blood PTH following TT was found to result in possible development of temporary hypocalcemia [12, 3539]. The systematic overview and meta-analysis conducted by Edafe et al. showed that patients with a decrease in post-operative PTH, to a level of 6–35 pg/mL, 1 h to 1 day following surgery, had a 69–100% chance of developing temporary hypocalcemia [9].
According to our data, the number of PGs identified during the surgery was a statistically significant predictor of the development of hypocalcemia. The greater the number of PGs found during surgery, the lower the chance of hypocalcemia. The study by Thomusch et al. determined that permanent post-operative hypocalcemia was more likely to develop if less than two PGs were found during surgery [40]. On the other hand, other studies have found that more PGs found during surgery may be associated with temporary hypocalcemia [12, 25, 41].
In our study, the number of PGs autotransplanted during surgery was a statistically reliable predictor of the development of post-TT hypocalcemia (p = 0.015). The greater the number of autotransplanted PGs, the higher the chance of hypocalcemia. Several studies have shown that autotransplantation of one or more PGs results in a far higher chance of hypocalcemia [12, 17, 18, 42]. However, several other studies showed no association between autotransplantation of PGs and permanent hypocalcemia [18, 25, 31, 43].
In our study, thyrotoxicosis <10 years before surgery was found to be a statistically reliable predictor of post-TT hypocalcemia (p = 0.046). Thyrotoxicosis >10 years before surgery was not significantly associated with post-TT hypocalcemia (p = 0.982); however, there were only 18 such patients (4.5%) in our study. Based on our data, Graves’ disease was not a statistically significant predictor of post-TT hypocalcemia (p = 0.247), but again, it was only diagnosed in 21 patients (5.3%). The multivariate analysis by Thomusch et al. demonstrated that, in patients with Graves’ disease, both temporary and permanent hypocalcemia developed more often following TT [40]. Further, a meta-analysis of four studies with 6681 patients showed a greater frequency of post-operative temporary hypocalcemia in patients with Graves’ disease [40, 4446].
Ligation of the trunk of the left inferior thyroid artery (p = 0.003) and the trunk of the right inferior thyroid artery (p < 0.001) were found to be statistically reliable predictors of hypocalcemia in our study. In a study of 1411 patients, Park et al. found that saving vessels supplying blood to the thyroid gland during surgery reduced the frequency of both temporary and permanent hypocalcemia in univariate (p = 0.01) and multivariate (p = 0.02) analyses [47]. According to Lee et al., saving veins on both sides of the thyroid may reduce post-TT hypocalcemia [48]. It has long been accepted that post-TT hypocalcemia depends on the experience of the surgeon and the surgical technique used [49, 50]. Our study identified some risk factors related to the surgical technique; hence, it is important not only to identify important factors following surgery that may influence development of hypocalcemia, but also to reconsider the surgical technique in order to minimize this risk, if possible.
In our study, the frequency analysis showed that neither gender (p = 0.351) nor age (p = 0.207) had a significant impact on development of hypocalcemia. However, in the multivariate analysis, female gender (p = 0.035) and older age (p = 0.029) were statistically significant predictors. There is no definitive evidence on the impact of age on the development of post-operative hypocalcemia in the literature. Some studies suggest that temporary post-operative hypocalcemia is more common in younger patients [15, 25], while others suggest it is more common in older patients [19, 21]. A meta-analysis of five studies with 2576 patients revealed no significant association between patient age and temporary hypocalcemia [15, 1719, 21]. While a meta-analysis of 10 studies involving 3443 patients showed that temporary post-operative hypocalcemia was more common in women [12, 15, 1721, 23, 41, 51].

Conclusions

This study demonstrates that there is a number of different patient (gender, age, and thyrotoxicosis <10 years before surgery) and surgical (number of PGs found observed surgery, decreased Ca and iCa before surgery, PTH on day one following surgery, and ligation of the trunk of the left and right inferior thyroid artery) risk factors predictive of the development of hypocalcemia following TT. Our study suggests that it is important not only to identify factors following surgery that may predict development of hypocalcemia, but also to reconsider the surgical technique, in order to minimize this risk, if possible. Identification of known risk factors post-operatively could allow for early detection and effective treatment of these patients.

Availability of data and materials

The datasets generated and analysed during the current study are available from the corresponding author on reasonable request.
This study was approved by Lithuanian Bioethics Committee (2014-12-02 No.: L-14-09/1, No.: L-14-09/2). Informed consent was obtained from all individual participants included in the study. The informed consent was in written.
Consent for publication was obtained from all individual participants included in the study. Consent for publication was in written.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.
Literatur
1.
Zurück zum Zitat Karamanakos SN, Markuo KB, Panagoppulos K, Karavias D, Vagianos CE, Scopa CD, et al. Complications and risk factors related to the extent of surgery in thyroidectomy-results from 2,043 procedures. Hormones. 2010;9:318–25.CrossRefPubMed Karamanakos SN, Markuo KB, Panagoppulos K, Karavias D, Vagianos CE, Scopa CD, et al. Complications and risk factors related to the extent of surgery in thyroidectomy-results from 2,043 procedures. Hormones. 2010;9:318–25.CrossRefPubMed
2.
Zurück zum Zitat Ho TW, Shaheen AA, Dixon E, Harvey A. Utilization of thyroidectomy for benign disease in the United States: a 15-year population-based study. Am J Surg. 2011;201:570–4.CrossRefPubMed Ho TW, Shaheen AA, Dixon E, Harvey A. Utilization of thyroidectomy for benign disease in the United States: a 15-year population-based study. Am J Surg. 2011;201:570–4.CrossRefPubMed
3.
Zurück zum Zitat Rosato L, Avenia N, Bernante P, De Palma M, Gulino G, Nasi PG, et al. Complications of thyroid surgery: analysis of a multicentric study on 14,934 patients operated on in Italy over 5 years. World J Surg. 2004;28:271–6.CrossRefPubMed Rosato L, Avenia N, Bernante P, De Palma M, Gulino G, Nasi PG, et al. Complications of thyroid surgery: analysis of a multicentric study on 14,934 patients operated on in Italy over 5 years. World J Surg. 2004;28:271–6.CrossRefPubMed
4.
Zurück zum Zitat Wilson RB, Erskine C, Crowe PJ. Hypomagnesemia and hypocalcemia after thyroidectomy: a prospective study. World J Surg. 2000;24:722–6.CrossRefPubMed Wilson RB, Erskine C, Crowe PJ. Hypomagnesemia and hypocalcemia after thyroidectomy: a prospective study. World J Surg. 2000;24:722–6.CrossRefPubMed
6.
Zurück zum Zitat Reeve T, Thompson NW. Complications of thyroid surgery: how to avoid them, how to manage them, and observations on their possible effect on the whole patient. World J Surg. 2000;24:971–5.CrossRefPubMed Reeve T, Thompson NW. Complications of thyroid surgery: how to avoid them, how to manage them, and observations on their possible effect on the whole patient. World J Surg. 2000;24:971–5.CrossRefPubMed
7.
Zurück zum Zitat D’Ajello F, Cirocchi R, Docimo G, Catania A, Ardito G, Rosato L, et al. Thyroidectomy with ultrasonic dissector: a multicentric experience. G Chir. 2010;31(6–7):289–92.PubMed D’Ajello F, Cirocchi R, Docimo G, Catania A, Ardito G, Rosato L, et al. Thyroidectomy with ultrasonic dissector: a multicentric experience. G Chir. 2010;31(6–7):289–92.PubMed
8.
Zurück zum Zitat Stack BC, Bimston DN, Bodenner DL, Brett EM, Dralle H, Orloff LA, et al. AACE/ACE disease state clinical review: postoperative hypoparathyroidism - definitions and management. Endocr Pract. 2015;21(6):674–85.CrossRefPubMed Stack BC, Bimston DN, Bodenner DL, Brett EM, Dralle H, Orloff LA, et al. AACE/ACE disease state clinical review: postoperative hypoparathyroidism - definitions and management. Endocr Pract. 2015;21(6):674–85.CrossRefPubMed
9.
Zurück zum Zitat Edafe O, Antakis R, Laskar N, Uttley L, Balasubramanian SP. Systematic review and meta-analysis of predictors of post-thyroidectomy hypocalcaemia. Br J Surg. 2014;101(4):307–20.CrossRefPubMed Edafe O, Antakis R, Laskar N, Uttley L, Balasubramanian SP. Systematic review and meta-analysis of predictors of post-thyroidectomy hypocalcaemia. Br J Surg. 2014;101(4):307–20.CrossRefPubMed
10.
Zurück zum Zitat Demeester-Mirkine N, Hooghe L, Van Geertruyden J, De Maetelaer V. Hypocalcemia after thyroidectomy. Arch Surg. 1992;127:854–8.CrossRefPubMed Demeester-Mirkine N, Hooghe L, Van Geertruyden J, De Maetelaer V. Hypocalcemia after thyroidectomy. Arch Surg. 1992;127:854–8.CrossRefPubMed
11.
Zurück zum Zitat Lemaire FX, Debruyne F, Delaere P, Vander Porten V. Parathyroid function in the early postoperative period after thyroidectomy. Acta Otorhinolaryngol Belg. 2001;55:187–97.PubMed Lemaire FX, Debruyne F, Delaere P, Vander Porten V. Parathyroid function in the early postoperative period after thyroidectomy. Acta Otorhinolaryngol Belg. 2001;55:187–97.PubMed
12.
Zurück zum Zitat Lang BH, Yih PC, Ng KK. A prospective evaluation of quick intraoperative parathyroid hormone assay at the time of skin closure in predicting clinically relevant hypocalcemia after thyroidectomy. World J Surg. 2012;36:1300–6.CrossRefPubMedPubMedCentral Lang BH, Yih PC, Ng KK. A prospective evaluation of quick intraoperative parathyroid hormone assay at the time of skin closure in predicting clinically relevant hypocalcemia after thyroidectomy. World J Surg. 2012;36:1300–6.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Ali S, Yu C, Palmer FL, Ganly I, Shaha A, Shah JP, et al. Nomogram to aid selection of patients for short-stay thyroidectomy based on risk of postoperative hypocalcemia. Arch Otolaryngol Head Neck Surg. 2011;137:1154–60.CrossRefPubMed Ali S, Yu C, Palmer FL, Ganly I, Shaha A, Shah JP, et al. Nomogram to aid selection of patients for short-stay thyroidectomy based on risk of postoperative hypocalcemia. Arch Otolaryngol Head Neck Surg. 2011;137:1154–60.CrossRefPubMed
14.
Zurück zum Zitat Amir A, Sands NB, Tamilia M, Hier MP, Black MJ, Payne RJ. Preoperative serum calcium levels as an indicator of postthyroidectomy hypocalcemia. J Otolaryngol Head Neck Surg. 2010;39:654–8.PubMed Amir A, Sands NB, Tamilia M, Hier MP, Black MJ, Payne RJ. Preoperative serum calcium levels as an indicator of postthyroidectomy hypocalcemia. J Otolaryngol Head Neck Surg. 2010;39:654–8.PubMed
15.
Zurück zum Zitat Yamashita H, Noguchi S, Tahara K, Watanabe S, Uchino S, Kawamoto H, et al. Postoperative tetany in patients with graves’ disease: a risk factor analysis. Clin Endocrinol. 1997;47:71–7.CrossRef Yamashita H, Noguchi S, Tahara K, Watanabe S, Uchino S, Kawamoto H, et al. Postoperative tetany in patients with graves’ disease: a risk factor analysis. Clin Endocrinol. 1997;47:71–7.CrossRef
16.
Zurück zum Zitat Gentileschi P, Gacek IA, Manzelli A, Cascarella G, Sileri P, Lirosi F, et al. Early (1 hour) post-operative parathyroid hormone (PTH) measurement predicts hypocalcaemia after thyroidectomy: a prospective case-control single-institution study. Chir Ital. 2008;60:519–28.PubMed Gentileschi P, Gacek IA, Manzelli A, Cascarella G, Sileri P, Lirosi F, et al. Early (1 hour) post-operative parathyroid hormone (PTH) measurement predicts hypocalcaemia after thyroidectomy: a prospective case-control single-institution study. Chir Ital. 2008;60:519–28.PubMed
17.
Zurück zum Zitat Moriyama T, Yamashita H, Noguchi S, Takamatsu Y, Ogawa T, Watanabe S, et al. Intraoperative parathyroid hormone assay in patients with graves’ disease for prediction of postoperative tetany. World J Surg. 2005;29:1282–7.CrossRefPubMed Moriyama T, Yamashita H, Noguchi S, Takamatsu Y, Ogawa T, Watanabe S, et al. Intraoperative parathyroid hormone assay in patients with graves’ disease for prediction of postoperative tetany. World J Surg. 2005;29:1282–7.CrossRefPubMed
18.
Zurück zum Zitat Sitges-Serra A, Ruiz S, Girvent M, Manjón H, Dueñas JP, Sancho JJ. Outcome of protracted hypoparathyroidism after total thyroidectomy. Br J Surg. 2010;97:1687–95.CrossRefPubMed Sitges-Serra A, Ruiz S, Girvent M, Manjón H, Dueñas JP, Sancho JJ. Outcome of protracted hypoparathyroidism after total thyroidectomy. Br J Surg. 2010;97:1687–95.CrossRefPubMed
19.
Zurück zum Zitat Kamer E, Unalp HR, Erbil Y, Akguner T, Issever H, Tarcan E. Early prediction of hypocalcemia after thyroidectomy by parathormone measurement in surgical site irrigation fluid. Int J Surg. 2009;7:466–71.CrossRefPubMed Kamer E, Unalp HR, Erbil Y, Akguner T, Issever H, Tarcan E. Early prediction of hypocalcemia after thyroidectomy by parathormone measurement in surgical site irrigation fluid. Int J Surg. 2009;7:466–71.CrossRefPubMed
20.
Zurück zum Zitat Erbil Y, Barbaros U, Temel B, Turkoglu U, Issever H, Bozbora A, et al. The impact of age, vitamin D(3) level, and incidental parathyroidectomy on. Am J Surg. 2009;197:439–46.CrossRefPubMed Erbil Y, Barbaros U, Temel B, Turkoglu U, Issever H, Bozbora A, et al. The impact of age, vitamin D(3) level, and incidental parathyroidectomy on. Am J Surg. 2009;197:439–46.CrossRefPubMed
21.
Zurück zum Zitat Erbil Y, Bozbora A, Ozbey N, Issever H, Aral F, Ozarmagan S, et al. Predictive value of age and serum parathormone and vitamin D3 levels for postoperative hypocalcemia after total thyroidectomy for nontoxic multinodular goiter. Arch Surg. 2007;142:1182–7.CrossRefPubMed Erbil Y, Bozbora A, Ozbey N, Issever H, Aral F, Ozarmagan S, et al. Predictive value of age and serum parathormone and vitamin D3 levels for postoperative hypocalcemia after total thyroidectomy for nontoxic multinodular goiter. Arch Surg. 2007;142:1182–7.CrossRefPubMed
22.
Zurück zum Zitat Walsh SR, Kumar B, Coveney EC. Serum calcium slope predicts hypocalcaemia following thyroid surgery. Int J Surg. 2007;5:41–4.CrossRefPubMed Walsh SR, Kumar B, Coveney EC. Serum calcium slope predicts hypocalcaemia following thyroid surgery. Int J Surg. 2007;5:41–4.CrossRefPubMed
23.
Zurück zum Zitat Yamashita H, Murakami T, Noguchi S, Shiiba M, Watanabe S, Uchino S, et al. Postoperative tetany in graves disease: important role of vitamin D metabolites. Ann Surg. 1999;229:237–45.CrossRefPubMedPubMedCentral Yamashita H, Murakami T, Noguchi S, Shiiba M, Watanabe S, Uchino S, et al. Postoperative tetany in graves disease: important role of vitamin D metabolites. Ann Surg. 1999;229:237–45.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Luu Q, Andersen PE, Adams J, Wax MK, Cohen JI. The predictive value of perioperative calcium levels after thyroid/parathyroid surgery. Head Neck. 2002;24:63–7.CrossRefPubMed Luu Q, Andersen PE, Adams J, Wax MK, Cohen JI. The predictive value of perioperative calcium levels after thyroid/parathyroid surgery. Head Neck. 2002;24:63–7.CrossRefPubMed
25.
Zurück zum Zitat Hallgrimsson P, Nordenström E, Almquist M, Bergenfelz AO. Risk factors for medically treated hypocalcemia after surgery for graves’ disease: a Swedish multicenter study of 1,157 patients. World J Surg. 2012;36:1933–42.CrossRefPubMed Hallgrimsson P, Nordenström E, Almquist M, Bergenfelz AO. Risk factors for medically treated hypocalcemia after surgery for graves’ disease: a Swedish multicenter study of 1,157 patients. World J Surg. 2012;36:1933–42.CrossRefPubMed
26.
Zurück zum Zitat Díez Alonso M, Sánchez López JD, Sánchez-Seco Peña MI, Ratia Jimenez T, Arribas Gomez I, Rodriguez Pascual A, et al. Serum PTH levels as a predictive factor of hypocalcaemia after total thyroidectomy. Cir Esp. 2009;85:96–102.CrossRefPubMed Díez Alonso M, Sánchez López JD, Sánchez-Seco Peña MI, Ratia Jimenez T, Arribas Gomez I, Rodriguez Pascual A, et al. Serum PTH levels as a predictive factor of hypocalcaemia after total thyroidectomy. Cir Esp. 2009;85:96–102.CrossRefPubMed
27.
Zurück zum Zitat Graff AT, Miller FR, Roehm CE, Prihoda TJ. Predicting hypocalcemia after total thyroidectomy: parathyroid hormone level vs. serial calcium levels. Ear Nose Throat J. 2010;89:462–5.PubMed Graff AT, Miller FR, Roehm CE, Prihoda TJ. Predicting hypocalcemia after total thyroidectomy: parathyroid hormone level vs. serial calcium levels. Ear Nose Throat J. 2010;89:462–5.PubMed
28.
Zurück zum Zitat Alia P, Moreno P, Rigo R, Francos JM, Navarro MA. Postresection parathyroid hormone and parathyroid hormone decline accurately predict hypocalcemia after thyroidectomy. Am J Clin Pathol. 2007;127:592–7.CrossRefPubMed Alia P, Moreno P, Rigo R, Francos JM, Navarro MA. Postresection parathyroid hormone and parathyroid hormone decline accurately predict hypocalcemia after thyroidectomy. Am J Clin Pathol. 2007;127:592–7.CrossRefPubMed
29.
Zurück zum Zitat Wong C, Price S, Scott-Coombes D. Hypocalcaemia and parathyroid hormone assay following total thyroidectomy: predicting the future. World J Surg. 2006;30:825–32.CrossRefPubMed Wong C, Price S, Scott-Coombes D. Hypocalcaemia and parathyroid hormone assay following total thyroidectomy: predicting the future. World J Surg. 2006;30:825–32.CrossRefPubMed
30.
Zurück zum Zitat Roh JL, Park CI. Intraoperative parathyroid hormone assay for management of patients undergoing total thyroidectomy. Head Neck. 2006;28:990–7.CrossRefPubMed Roh JL, Park CI. Intraoperative parathyroid hormone assay for management of patients undergoing total thyroidectomy. Head Neck. 2006;28:990–7.CrossRefPubMed
31.
Zurück zum Zitat Aluffi P, Aina E, Bagnati T, Toso A, Pia F. Prognostic factors for definitive hypoparathyroidism following total thyroidectomy. Acta Otorrinolaringol Esp. 2008;59:321–4.CrossRefPubMed Aluffi P, Aina E, Bagnati T, Toso A, Pia F. Prognostic factors for definitive hypoparathyroidism following total thyroidectomy. Acta Otorrinolaringol Esp. 2008;59:321–4.CrossRefPubMed
32.
Zurück zum Zitat Pisanu A, Cois A, Piu S, Altana ML, Uccheddu A. Factors predicting outcome of hypocalcaemia following total thyroidectomy. Chir Ital. 2003;55:35–40.PubMed Pisanu A, Cois A, Piu S, Altana ML, Uccheddu A. Factors predicting outcome of hypocalcaemia following total thyroidectomy. Chir Ital. 2003;55:35–40.PubMed
33.
Zurück zum Zitat Pattou F, Combemale F, Fabre S, Carnaille B, Decoulx M, Wemeau JL, et al. Hypocalcemia following thyroid surgery: incidence and prediction of outcome. World J Surg. 1998;22:718–24.CrossRefPubMed Pattou F, Combemale F, Fabre S, Carnaille B, Decoulx M, Wemeau JL, et al. Hypocalcemia following thyroid surgery: incidence and prediction of outcome. World J Surg. 1998;22:718–24.CrossRefPubMed
34.
Zurück zum Zitat Tartaglia F, Giuliani A, Sgueglia M, Patrizi G, Di Rocco G, Blasi S, et al. Is ionized calcium a reliable predictor of hypocalcemia after total thyroidectomy? A before and after study. G Chir. 2014;35(1/2):27–35.PubMedPubMedCentral Tartaglia F, Giuliani A, Sgueglia M, Patrizi G, Di Rocco G, Blasi S, et al. Is ionized calcium a reliable predictor of hypocalcemia after total thyroidectomy? A before and after study. G Chir. 2014;35(1/2):27–35.PubMedPubMedCentral
35.
Zurück zum Zitat Chapman DB, French CC, Leng X, Browne JD, Waltonen JD, Sullivan CA. Parathyroid hormone early percent change: an individualized approach to predict postthyroidectomy hypocalcemia. Am J Otolaryngol. 2012;33:216–20.CrossRefPubMed Chapman DB, French CC, Leng X, Browne JD, Waltonen JD, Sullivan CA. Parathyroid hormone early percent change: an individualized approach to predict postthyroidectomy hypocalcemia. Am J Otolaryngol. 2012;33:216–20.CrossRefPubMed
36.
Zurück zum Zitat Kovacevic B, Ignjatovic M, Cuk V, Zivaljevic V, Paunovic I. Early prediction of symptomatic hypocalcemia after total thyroidectomy. Acta Chir Belg. 2011;111:303–7. Kovacevic B, Ignjatovic M, Cuk V, Zivaljevic V, Paunovic I. Early prediction of symptomatic hypocalcemia after total thyroidectomy. Acta Chir Belg. 2011;111:303–7.
37.
Zurück zum Zitat Proczko-Markuszewska M, Kobiela J, Stefaniak T, Lachiński AJ, Sledziński Z. Postoperative PTH measurement as a predictor of hypocalcaemia after thyroidectomy. Acta Chir Belg. 2010;110:40–4.CrossRefPubMed Proczko-Markuszewska M, Kobiela J, Stefaniak T, Lachiński AJ, Sledziński Z. Postoperative PTH measurement as a predictor of hypocalcaemia after thyroidectomy. Acta Chir Belg. 2010;110:40–4.CrossRefPubMed
38.
Zurück zum Zitat Vanderlei FA, Vieira JG, Hojaij FC, Cervantes O, Kunii IS, Ohe MN, et al. Parathyroid hormone: an early predictor of symptomatic hypocalcemia after total thyroidectomy. Arq Bras Endocrinol Metabol. 2012;56:168–72.CrossRefPubMed Vanderlei FA, Vieira JG, Hojaij FC, Cervantes O, Kunii IS, Ohe MN, et al. Parathyroid hormone: an early predictor of symptomatic hypocalcemia after total thyroidectomy. Arq Bras Endocrinol Metabol. 2012;56:168–72.CrossRefPubMed
39.
Zurück zum Zitat Lecerf P, Orry D, Perrodeau E, Lhommet C, Charretier C, Mor C, et al. Parathyroid hormone decline 4 hours after total thyroidectomy accurately predicts hypocalcemia. Surgery. 2012;152:863–8.CrossRefPubMed Lecerf P, Orry D, Perrodeau E, Lhommet C, Charretier C, Mor C, et al. Parathyroid hormone decline 4 hours after total thyroidectomy accurately predicts hypocalcemia. Surgery. 2012;152:863–8.CrossRefPubMed
40.
Zurück zum Zitat Thomusch O, Machens A, Sekulla C, Ukkat J, Brauckhoff M, Dralle H. The impact of surgical technique on postoperative hypoparathyroidism in bilateral thyroid surgery: a multivariate analysis of 5846 consecutive patients. Surgery. 2003;133:180–5.CrossRefPubMed Thomusch O, Machens A, Sekulla C, Ukkat J, Brauckhoff M, Dralle H. The impact of surgical technique on postoperative hypoparathyroidism in bilateral thyroid surgery: a multivariate analysis of 5846 consecutive patients. Surgery. 2003;133:180–5.CrossRefPubMed
41.
Zurück zum Zitat Pfleiderer AG, Ahmad N, Draper MR, Vrotsou K, Smith WK. The timing of calcium measurements in helping to predict temporary and permanent hypocalcaemia in patients having completion and total thyroidectomies. Ann R Coll Surg Engl. 2009;91:140–6.CrossRefPubMedPubMedCentral Pfleiderer AG, Ahmad N, Draper MR, Vrotsou K, Smith WK. The timing of calcium measurements in helping to predict temporary and permanent hypocalcaemia in patients having completion and total thyroidectomies. Ann R Coll Surg Engl. 2009;91:140–6.CrossRefPubMedPubMedCentral
42.
Zurück zum Zitat Asari R, Passler C, Kaczirek K, Scheuba C, Niederle B. Hypoparathyroidism after total thyroidectomy: a prospective study. Arch Surg. 2008;143:132–7.CrossRefPubMed Asari R, Passler C, Kaczirek K, Scheuba C, Niederle B. Hypoparathyroidism after total thyroidectomy: a prospective study. Arch Surg. 2008;143:132–7.CrossRefPubMed
43.
Zurück zum Zitat Promberger R, Ott J, Kober F, Mikola B, Karik M, Freissmuth M, et al. Intra- and postoperative parathyroid hormone-kinetics do not advocate for autotransplantation of discolored parathyroid glands during thyroidectomy. Thyroid. 2010;20:1371–5.CrossRefPubMed Promberger R, Ott J, Kober F, Mikola B, Karik M, Freissmuth M, et al. Intra- and postoperative parathyroid hormone-kinetics do not advocate for autotransplantation of discolored parathyroid glands during thyroidectomy. Thyroid. 2010;20:1371–5.CrossRefPubMed
45.
Zurück zum Zitat Welch KC, McHenry CR. Total thyroidectomy: is morbidity higher for graves’ disease than nontoxic goiter? J Surg Res. 2011;170:96–9.CrossRefPubMed Welch KC, McHenry CR. Total thyroidectomy: is morbidity higher for graves’ disease than nontoxic goiter? J Surg Res. 2011;170:96–9.CrossRefPubMed
46.
Zurück zum Zitat Chiang FY, Lin JC, Wu CW, Lee KW, Lu SP, Kuo WR, et al. Morbidity after total thyroidectomy for benign thyroid disease: comparison of graves’ disease and non-graves’ disease. Kaohsiung J Med Sci. 2006;22:554–9.CrossRefPubMed Chiang FY, Lin JC, Wu CW, Lee KW, Lu SP, Kuo WR, et al. Morbidity after total thyroidectomy for benign thyroid disease: comparison of graves’ disease and non-graves’ disease. Kaohsiung J Med Sci. 2006;22:554–9.CrossRefPubMed
47.
Zurück zum Zitat Park I, Rhu J, Woo J-W, Choi JH, Kim JS, Kim JH. Preserving parathyroid gland vasculature to reduce post-thyroidectomy hypocalcemia. World J Surg. 2016;40:1382–9.CrossRefPubMed Park I, Rhu J, Woo J-W, Choi JH, Kim JS, Kim JH. Preserving parathyroid gland vasculature to reduce post-thyroidectomy hypocalcemia. World J Surg. 2016;40:1382–9.CrossRefPubMed
48.
Zurück zum Zitat Lee DY, Cha W, Jeong WJ, Ahn SH. Preservation of the inferior thyroidal vein reduces post-thyroidectomy hypocalcemia. Laryngoscope. 2014;124:1272–7.CrossRefPubMed Lee DY, Cha W, Jeong WJ, Ahn SH. Preservation of the inferior thyroidal vein reduces post-thyroidectomy hypocalcemia. Laryngoscope. 2014;124:1272–7.CrossRefPubMed
49.
Zurück zum Zitat Sosa JA, Bowman HM, Tielsch JM, Powe NR, Gordon TA, Udelsman R. The importance of surgeon experience for clinical and economic outcomes from thyroidectomy. Ann Surg. 1998;228(3):320–30.CrossRefPubMedPubMedCentral Sosa JA, Bowman HM, Tielsch JM, Powe NR, Gordon TA, Udelsman R. The importance of surgeon experience for clinical and economic outcomes from thyroidectomy. Ann Surg. 1998;228(3):320–30.CrossRefPubMedPubMedCentral
50.
Zurück zum Zitat Kandil E, Noureldine SI, Abbas A, Tufano RP. The impact of surgical volume on patient outcomes following thyroid surgery. Surgery. 2013;154(6):1346–53.CrossRefPubMed Kandil E, Noureldine SI, Abbas A, Tufano RP. The impact of surgical volume on patient outcomes following thyroid surgery. Surgery. 2013;154(6):1346–53.CrossRefPubMed
51.
Zurück zum Zitat Sands NB, Payne RJ, Cote V, Hier MP, Black MJ, Tamilia M. Female gender as a risk factor for transient post-thyroidectomy hypocalcemia. Otolaryngol Head Neck Surg. 2011;145:561–4.CrossRefPubMed Sands NB, Payne RJ, Cote V, Hier MP, Black MJ, Tamilia M. Female gender as a risk factor for transient post-thyroidectomy hypocalcemia. Otolaryngol Head Neck Surg. 2011;145:561–4.CrossRefPubMed
Metadaten
Titel
Predictors of postoperative hypocalcemia occurring after a total thyroidectomy: results of prospective multicenter study
verfasst von
Vitalijus Eismontas
Algirdas Slepavicius
Vinsas Janusonis
Paulius Zeromskas
Virgilijus Beisa
Kestutis Strupas
Zilvinas Dambrauskas
Antanas Gulbinas
Arvydas Martinkenas
Publikationsdatum
01.12.2018
Verlag
BioMed Central
Erschienen in
BMC Surgery / Ausgabe 1/2018
Elektronische ISSN: 1471-2482
DOI
https://doi.org/10.1186/s12893-018-0387-2

Weitere Artikel der Ausgabe 1/2018

BMC Surgery 1/2018 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.